PhosphdiesteRasE-5 inhibition to improve CLinical status and EXercise capacity in diastolic heart failure (RELAX) trial: Rationale and design

Margaret M. Redfield, Barry A. Borlaug, Greg D. Lewis, Selma F. Mohammed, Marc J. Semigran, Martin M. Lewinter, Anita Deswal, Adrian F. Hernandez, Kerry L. Lee, Eugene Braunwald

Research output: Contribution to journalArticle

88 Scopus citations
Original languageEnglish (US)
Pages (from-to)653-659
Number of pages7
JournalCirculation: Heart Failure
Issue number5
StatePublished - Sep 1 2012


  • Diastolic heart failure
  • Heart failure
  • Phosphodiesterase inhibitor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this